A Case series of Neonatal Inflammatory Syndrome (MIS-N) with rare clinical manifestations
Multisystem inflammatory syndrome in neonates (MIS-N) is hypothesized to be caused either following transplacental transfer of SARS-CoV2 antibodies. MIS-N presents with a variety of clinical presentations and requires a high index of suspicion.
Diggikar S, Nanjegowda R, Kumar A, et al. Neonatal multisystem inflammatory syndrome secondary to SARS CoV 2 infection. J Paediatr Child Health. 2021. Aug 13:10.1111/jpc.1569.
Lakshminrusimha S, Hudak ML, Dimitriades VR, Higgins RD. Multisystem inflammatory syndrome in neonates following maternal SARS-CoV-2 infection. Am J Perinatol. 2021.
Pawar R, Gavade V, Patil N, et al. Neonatal multisystem inflammatory syndrome (MIS-N) associated with prenatal maternal SARS-CoV-2: A case series. Children. 2021;8:572
Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S (2020) Multi-System Inflammatory Syndrome in Children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management.
Kappanayil M, Balan S, Alawani S, et al. Multisystem inflammatory syndrome in a neonate, temporally associated with prenatal exposure to SARS-CoV-2: A case report. Lancet Child Adolesc. Health. 2021;5:304-8.